z-logo
Premium
The initial management of multiple myeloma in the era of novel agents: 2021 and beyond
Author(s) -
Nadeem Omar,
Richardson Paul G.
Publication year - 2021
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.17407
Subject(s) - medicine , chimeric antigen receptor , minimal residual disease , panobinostat , multiple myeloma , transplantation , oncology , immunology , immunotherapy , cancer research , histone deacetylase , biology , histone , cancer , bone marrow , biochemistry , gene

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom